Investigators at the Center for Structural Genomics of Infectious Diseases (CSGID) and the Seattle Structural Genomics Center for Infectious Disease (SSGCID) announced today that they reached a significant milestone by determining 1,000 protein structures from infectious disease organisms. The knowledge gained from these structures should lead to new interventions for the deadly diseases caused by these pathogens.
Since 2007, the SSGCID, headed by Dr. Peter J. Myler of Seattle Biomedical Research Institute (Seattle BioMed), and the CSGID, headed Dr. Wayne Anderson, Molecular Pharmacology and Biological Chemistry at the Northwestern University Feinberg School of Medicine, have been funded by five-year contracts from the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH).
Researchers in both centers use X-ray crystallography and nuclear magnetic resonance to examine the atomic details of proteins from more than 40 human pathogens, including those responsible for the plague, anthrax, salmonellosis, cholera, tuberculosis (TB), leprosy, amoebic dysentery and influenza. The proteins are selected for their biomedical relevance, as well as potential therapeutic and diagnostic benefits, with one-third being direct requests from the infectious disease research community. “We are laying the groundwork for drug discovery,” Anderson says. “Determining protein structures can help researchers find potential targets for new drugs, essential enzymes, and possible vaccine candidates.” Myler adds, “The importance of this work is highlighted by the 80+ scientific articles published by the two centers, which also showcase new methodologies developed by each center.”
One of the major challenges in medicine today is fighting bacteria that have become drug-resistant. Methicillin-resistant Staphylococcus aureus, commonly known as MRSA, is incredibly difficult to treat because it has developed a resistance to antibiotics, including penicillin and cephalosporins. “By determining the structure of proteins targeted by these drugs, we can now look at how the atoms are arranged in space and how they interact with one another,” Anderson says. “Then researchers can determine how the bacterium developed resistance and figure out what to change in the drug so that the bacteria will not recognize it.” Dr. Lance Stewart, co-PI of the SSGCID, continues, “The emergence of multi-drug resistant strains of Mycobacterium tuberculosis (MDR-TB), is also an important global health concern, with the most recent cases of TB emerging from India being considered extensively drug resistant (XDR-TB).” The World Health Organization (WHO) and other global health authorities have called for a concerted effort to identify new therapeutic agents for new and better drugs to combat TB, especially medications directed at treating drug resistant strains of the disease. The SSGCID has solved 22 structures from M. tuberculosis and an additional 126 closely related targets from other Mycobacterium species, which cause diseases such as leprosy, Buruli ulcer, and lung infections in AIDS patients. These structures will aid in the understanding of these deadly diseases, as well as providing a blueprint for development of new drugs.
When the two structural genomics centers originally received NIH funding, their expectation was to solve 750 structures, combined, over five years. However, both centers have been driven to exceed this goal by the need for structural data for these pathogens. Advances in technology and the efficiency of both teams allowed them to far exceed their initial goal, even before completion of the 5-year contract. “It used to take four years to determine one structure,” Anderson says, “now we can do about three per week.” Myler says, “The interaction of our centers with more than two hundred scientific collaborators will greatly accelerate drug development and understanding of the biology of these organisms.” Each institution in the two consortia contributes to different aspects of the high-throughput pipeline, which include selecting target proteins using bioinformatics, cloning their genes into bacteria for protein production, purification, and crystallization, with X-ray diffraction data collected at 9 different beam-lines around the United States and Canada. After the protein structures are solved, their coordinates are made available freely to the research community by deposition in the NIH-supported Protein Data Bank. The structures can also be accessed at the CSGID and SSGCID websites.
Members of the scientific community interested in nominating protein targets for structural determination can complete a request form on the SSGCID or CSGID website. This service is offered free of charge to the scientific community, and both centers also freely distribute the protein expression clones via the NIH-funded Biodefense and Emerging Infections Research Resources Repository.
Members of the SSGCID include Seattle BioMed (Seattle, WA), Emerald BioStructures (Bainbridge Island, WA), the University of Washington (Seattle, WA) and Pacific Northwest National Laboratory (Richland, WA). The CSGID is a multi-institutional, international consortium including researchers from the Northwestern University (Chicago, IL), University of Chicago (Chicago, IL), the J. Craig Venter Institute (Rockville, MD), University College London (London, United Kingdom), Sanford-Burnham Medical Research Institute (San Diego, CA), the University of Toronto (Toronto, Canada), the University of Virginia (Charlottesville, VA), the University of Texas Southwestern Medical Center at Dallas (Dallas, TX), and the Washington University School of Medicine (St. Louis, MO). For more information about the CSGID and SSGCID, respectively, and to view the protein target lists, visit http://www.csgid.org and http://www.ssgcid.org. CSGID and SSGCID have been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract Numbers HHSN272200700058C and HHSN272200700057C, respectively.For more information, contact:
Jennifer Mortensen | EurekAlert!
Further reports about: > Allergy > BioMed > Disease > Genomics > Infectious Diseases > Medical Wellness > Medicine > Mycobacterium > Protein > SSGCID > Structural Biology Laboratory > X-ray microscopy > deadly disease > global health > health services > infectious disease > infectious outbreaks > protein structure
Why might reading make myopic?
18.07.2018 | Universitätsklinikum Tübingen
Unique brain 'fingerprint' can predict drug effectiveness
11.07.2018 | McGill University
For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.
To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...
For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.
Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...
Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.
A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...
Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.
"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....
Ultra-short, high-intensity X-ray flashes open the door to the foundations of chemical reactions. Free-electron lasers generate these kinds of pulses, but there is a catch: the pulses vary in duration and energy. An international research team has now presented a solution: Using a ring of 16 detectors and a circularly polarized laser beam, they can determine both factors with attosecond accuracy.
Free-electron lasers (FELs) generate extremely short and intense X-ray flashes. Researchers can use these flashes to resolve structures with diameters on the...
13.07.2018 | Event News
12.07.2018 | Event News
03.07.2018 | Event News
19.07.2018 | Materials Sciences
19.07.2018 | Earth Sciences
19.07.2018 | Life Sciences